Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies

by Livingstone Fultang, Luciana Gneo, Carmela De Santo, Francis J. Mussai
Published 2021-05-01

MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancersResearch in Context

by Livingstone Fultang, Silvia Panetti, Margaret Ng, Paul Collins, Suzanne Graef, Nagy Rizkalla, Sarah Booth, Richard Lenton, Boris Noyvert, Claire Shannon-Lowe, Gary Middleton, Francis Mussai, Carmela De Santo
Published 2019-09-01